ProCE Banner Activity

A Regionally Focused Quality Improvement Initiative to Optimize Care of Patients With Obesity and Type 2 Diabetes: Engaging Patients for Long-term Weight Loss

Slideset

In these unlocked downloadable slides, an expert reviews strategies for engaging patients in nonjudgmental discussions about weight and individual weight loss goals to promote long-term weight loss.

Released: February 19, 2024

Share

Faculty

Donna H. Ryan

Donna H. Ryan, MD

Professor Emerita
Pennington Biomedical Research Center
Baton Rouge, Louisiana

Provided by

Provided by Clinical Care Options, LLC in partnership with the National AHEC Organization.

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Partners

National AHEC Organization

ProCE Banner

Target Audience

This program is intended for healthcare professionals who care for patients with malignant or nonmalignant hematologic disorders.

Program Learning Goal

This activity aims to improve learners’ understanding of how to optimally apply recent practice-changing findings in the treatment of patients with malignant or nonmalignant hematologic disorders.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply recently presented data to clinical practice to expand treatment options and improve outcomes for patients with malignant or nonmalignant hematologic disorders

  • Evaluate new data on novel agents and therapeutic approaches for patients with malignant or nonmalignant hematologic disorders

  • Appraise how new trial findings might affect treatment of patients with malignant or nonmalignant hematologic disorders in the future

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Donna H. Ryan, MD

Professor Emerita
Pennington Biomedical Research Center
Baton Rouge, Louisiana

Donna H. Ryan, MD: consultant/advisor/speaker: Altimmune, Amgen, Biohaven, Calibrate, Carmot, CinRX, Epitome, Gila, Ifa Celtic, Lilly, Novo Nordisk, Scientific Intake, Structure RX, Wonder Health and Zealand, Xeno Bioscience; stock/stock options: Calibrate, Epitomee, Scientific Intake, Xeno Bioscience; data safety monitoring committee: Lilly. 

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Kristi K. Orbaugh, MSN, NP, AOCNP, as noted below.

Kristi K. Orbaugh, MSN, NP, AOCNP: consultant/advisor/speaker: AstraZeneca, Bristol Myers Squibb, CTI, DSI, Gilead, Lilly, MorphoSys, Pfizer.

Instructions for Credit

Participation in this self-study activity should be completed in approximately hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from February 19, 2024, through :

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician Continuing Medical Education
CCO designates this enduring material for a maximum of AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number - xxxx
Type of Activity: Application

Upon successfully completing the post-test with a score of or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days. 

Physician Associate Continuing Medical Education
Joint AccreditationClinical Care Option, LLC  has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for AAPA Category 1 CME credits. Approval is valid until  . PAs should only claim credit commensurate with the extent of their participation.